Host-bacterial interactions in inflammatory bowel disease

Clinical Science

Volumn 107, Issue 4, 2004, Pages 331-341

  Mahida, Yashwant R ^a   Rolfe, Vivien E ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Crohn's disease; Host bacterial interaction; Inflammatory bowel disease; Mucosa; Probiotics; Therapeutics; Ulcerative colitis

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM LONGUM INFANTIS; CROHN DISEASE; ENTERITIS; HOST PATHOGEN INTERACTION; HUMAN; INFLAMMATION; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

ANIMALS; ANTIGENS, BACTERIAL; BIFIDOBACTERIUM; CYTOKINES; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LACTOBACILLUS; MODELS, ANIMAL; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS;

EID: 6344287661     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20040136     Document Type: Review

References (129)

1. Simon, G. L. and Gorbach, S. L. (1984) Intestinal flora in health and disease. Gastroenterology 86, 174-193
2. Stephen, A. M. and Cummings, J. H. (1980) The microbial contribution to human faecal mass. J. Med. Microbiol. 13, 45-56
3. Moore, W. E. and Holdeman, L. V. (1974) Special problems associated with the isolation and identification of intestinal bacteria in fecal flora studies. Am. J. Clin. Nutr. 27, 1450-1455
4. Harmsen, H. J., Gibson, G. R., Elfferich, P. et al. (2000) Comparison of viable cell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human fecal bacteria. FEMS Microbiol. Lett. 183, 125-129
5. Mountzouris, K. C., McCartney, A. L. and Gibson, G. R. (2002) Intestinal microflora of human infants and current trends for its nutritional modulation. Br. J. Nutr. 87, 405-420
6. Tannock, G. W., Fuller, R., Smith, S. L. and Hall, M. A. (1990) Plasmid profiling of members of the family Enterobacteriaceae, lactobacilli, and bifidobacteria to study the transmission of bacteria from mother to infant. J. Clin. Microbiol. 28, 1225-1228
7. Fanaro, S., Chierici, R., Guerrini, P. and Vigi, V. (2003) Intestinal microflora in early infancy: composition and development. Acta Paediatr. 91 (Suppl.), 48-55
8. Bry, L., Falk, P. G., Midtvedt, T. and Gordon, J. I. (1996) A model of host-microbial interactions in an open mammalian ecosystem. Science (Washington, D.C.) 273, 1380-1383
9. Hooper, L. V., Xu, J., Falk, P. G., Midtvedt, T. and Gordon, J. I. (1999) A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc. Natl. Acad. Sci. U.S.A. 96, 9833-9838
10. Vaahtovuo, J., Toivanen, P. and Eerola, E. (2003) Bacterial composition of murine fecal microflora is indigenous and genetically guided. FEMS Microbiol. Ecol. 44, 131-136
11. Umesaki, Y. and Setoyama, H. (2000) Structure of the intestinal flora responsible for development of the gut immune system in a rodent model. Microbes Infect. 2, 1343-1351
12. Klaasen, H. L., Van der Heijden, P.J., Stok, W. et al. (1993) Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice. Infect. Immun. 61, 303-306
13. Savage, D. C. (1977) Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 31, 107-133
14. Hartley, C. L., Clements, H. M. and Linton, K. B. (1977) Escherichia coli in the faecal flora of man. J. Appl. Bacteriol. 43, 261-269
15. McCartney, A. L., Wenzhi, W. and Tannock, G. W. (1996) Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans. Appl. Environ. Microbiol. 62, 4608-4613
16. Gorbach, S. L., Nahas, L., Lerner, P. I. and Weinstein, L. (1967) Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology 53, 845-855
17. Hopkins, M. J., Sharp, R. and Macfarlane, G. T. (2001) Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 48, 198-205
18. Hopkins, M. J., Sharp, R. and Macfarlane, G. T. (2002) Variation in human intestinal microbiota with age. Dig. Liver Dis. 34, S12-S18
19. Janeway, C. A. (2001) How the immune system protects the host from infection. Microbes Infect. 3, 1167-1171
20. Medzhitov, R. and Janeway, Jr, C. A. (2002) Decoding the patterns of self and nonself by the innate immune system. Science (Washington, D.C.) 296, 298-300
21. Underhill, D. M. and Ozinsky, A. (2002) Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 14, 103-110
22. Takeda, K., Kaisho, T. and Akira, S. (2003) Toll-like receptors. Annu. Rev. Immunol. 21, 335-376
23. Mahida, Y. R. and Johal, S. (2001) NF-κB may determine whether epithelial cell-microbial interactions in the intestine are hostile or friendly. Clin. Exp. Immun. 123, 347-349
24. Girardin, S. E., Hugot, J. P. and Sansonetti, P. J. (2003) Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing. Trends Immunol. 24, 652-658
25. Inohara, N. and Nunez, G. (2003) NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3, 371-382
26. Girardin, S. E., Boneca, I. G., Carneiro, L. A. et al. (2003) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science (Washington, D.C.) 300, 1584-1587
27. Inohara, N., Ogura, Y., Fontalba, A. et al. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278, 5509-5512
28. Girardin, S. E., Boneca, I. G., Viala, J. et al. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869-8872
29. Bonen, D. K. and Cho, J. H. (2003) The genetics of inflammatory bowel disease. Gastroenterology 124, 521-536
30. Van Heel, D. A., McGovern, D. P. and Jewell, D. P. (2001) Crohn's disease: genetic susceptibility, bacteria, and innate immunity. Lancet 357, 1902-1904
31. Girardin, S. E., Tournebize, R., Mavris, M. et al. (2001) CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2, 736-742
32. Mahida, Y. R., Makh, S., Hyde, S., Gray, T. and Borriello, S. P. (1996) Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. Gut 38, 337-347
33. Branka, J. E., Vallette, G., Jarry, A. et al. (1997) Early functional effects of Clostridium difficile toxin A on human colonocytes. Gastroenterology 112, 1887-1894
34. Abreu, M. T., Vora, P., Faure, E., Thomas, L. S., Arnold, E. T. and Arditi, M. (2001) Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167, 1609-1616
35. Melmed, G., Thomas, L. S., Lee, N. et al. (2003) Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J. Immunol. 170, 1406-1415
36. Cario, E. and Podolsky, D. K. (2000) Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68, 7010-7017
37. Hornef, M. W., Frisan, T., Vandewalle, A., Normark, S. and Richter-Dahlfors, A. (2002) Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. Med. 195, 559-570
38. Gewirtz, A. T., Navas, T. A., Lyons, S., Godowski, P. J. and Madara, J. L. (2001) Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167, 1882-1885
39. Neish, A. S., Gewirtz, A. T., Zeng, H. et al. (2000) Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science (Washington, D.C.) 289, 1560-1563
40. Haller, D., Bode, C., Hammes, W. P., Pfeifer, A. M., Schiffrin, E. J. and Blum, S. (2000) Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47, 79-87
41. Wong, W. M., Poulsom, R. and Wright, N. A. (1999) Trefoil peptides. Gut 44, 890-895
42. Podolsky, D. K. (1999) Mucosal immunity and inflammation. V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am. J. Physiol. 277, G495-G499
43. Cunliffe, R. N. and Mahida, Y. R. (2004) Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J. Leukocyte Biol. 75, 49-58
44. Ouellette, A. J. and Bevins, C. L. (2001) Paneth cell defensins and innate immunity of the small bowel. Inflamm. Bowel Dis. 7, 43-50
45. Ganz, T. (2003) Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710-720
46. Rolfe, V. and Levin, R. J. (1994) Enterotoxin Escherichia coli STa activates a nitric oxide-dependent myenteric plexus secretory reflex in the rat ileum. J. Physiol. (Cambridge, U.K.) 475, 531-537
47. Brandtzaeg, P. and Farstad, I. N. (1999) The human mucosal B-cell system. In Mucosal Immunology, volume 2 (Ogra, P. L., Mestecky, J., Lamm, M. E., Strober, W., Bienenstock, J. and McGhee, J. R., eds.), pp. 439-468, Academic Press, San Diego
48. McGhee, J. R., Czerkinsky, C. and Mestecky, J. (1999) Mucosal vaccines: An Overview. In Mucosal Immunology, Volume 2 (Ogra, P. L., Mestecky, J., Lamm, M. E., Strober, W., Bienenstock, J. and McGhee, J. R., eds.), pp. 741-757, Academic Press, San Diego
49. Macpherson, A. J. and Uhr, T. (2004) Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science (Washington, D.C.) 303, 1662-1665
50. Suzuki, K., Meek, B., Doi, Y., Muramatsu, M., Chiba, T., Honjo, T. and Fagarasan, S. (2004) Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc. Natl. Acad. Sci. U.S.A. 101, 1981-1986
51. Fernandez, M. I., Pedron, T., Tournebize, R., Olivo-Marin, J. C., Sansonetti, P. J. and Phalipon, A. (2003) Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells. Immunity 18, 739-749
52. Mahida, Y. R. (2000) The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm. Bowel Dis. 6, 21-33
53. McAlindon, M. E., Hawkey, C. J. and Mahida, Y. R. (1998) Expression of interleukin 1β and interleukin 1β converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut 42, 214-219
54. Austin, A. S., Robins, A. and Mahida, Y. R. (2002) Characterisation of the expression of Toll-like receptor (TLR) 2, TLR 4, CD14 and responsiveness to lipopolysaccharide (LPS) by intestinal macrophages. Gastroenterology 122, M1099
55. Isaacs, K. L., Sartor, R. B. and Haskill, S. (1992) Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 103, 1587-1595
56. Cappello, M., Keshav, S., Prince, C., Jewell, D. P. and Gordon, S. (1992) Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut 33, 1214-1219
57. Murch, S. H., Braegger, C. P., Walker-Smith, J. A. and MacDonald, T. T. (1993) Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 34, 1705-1709
58. Cummings, J. H. (1981) Short chain fatty acids in the human colon. Gut 22, 763-779
59. Roediger, W. E. (1980) Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21, 793-798
60. Mee, A. S., McLaughlin, J. E., Hodgson, H. J. and Jewell, D. P. (1979) Chronic immune colitis in rabbits. Gut 20, 1-5
61. Onderdonk, A. B., Franklin, M. L. and Cisneros, R. L. (1981) Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infect. Immun. 32, 225-231
62. Onderdonk, A. B., Steeves, R. M., Cisneros, R. L. and Bronson, R. T. (1984) Adoptive transfer of immune enhancement of experimental ulcerative colitis. Infect. Immun. 46, 64-67
63. Strober, W., Fuss, I. J. and Blumberg, R. S. (2002) The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20, 495-549
64. Mahida, Y. R. (2001) Rodent models of chronic intestinal inflammation. In Immunological Aspects of Gastroenterology, volume 31 (Mahida, Y. R., ed.), pp. 241-263, Kluwer Academic Publishers, Dordrecht
65. Elson, C. O. and Cong, Y. (2002) Understanding immune-microbial homeostasis in intestine. Immunol. Res. 26, 87-94
66. Powrie, F., Read, S., Mottet, C., Uhlig, H. and Maloy, K. (2003) Control of immune pathology by regulatory T cells. Novartis Found. Symp. 252, 92-98
67. Harper, P. H., Lee, E. C., Kettlewell, M. G., Bennett, M. K. and Jewell, D. P. (1985) Role of the faecal stream in the maintenance of Crohn's colitis. Gut 26, 279-284
68. Cartun, R. W., Van Kruiningen, H. J., Pedersen, C. A. and Berman, M. M. (1993) An immunocytochemical search for infectious agents in Crohn's disease. Mod. Pathol. 6, 212-219
69. Liu, Y., van Kruiningen, H. J., West, A. B., Cartun, R. W., Cortot, A. and Colombel, J. F. (1995) Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 108, 1396-1404
70. Hudson, M. J., Hill, M. J., Elliott, P. R., Berghouse, L. M., Burnham, W. R. and Lennard-Jones, J. E. (1984) The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy. J. Med. Microbiol. 18, 335-345
71. Hartley, M. G., Hudson, M. J., Swarbrick, E. T. et al. (1992) The rectal mucosa-associated microflora in patients with ulcerative colitis. J. Med. Microbiol. 36, 96-103
72. Poxton, I. R., Brown, R., Sawyerr, A. and Ferguson, A. (1997) Mucosa-associated bacterial flora of the human colon. J. Med. Microbiol. 46, 85-91
73. Edmiston, Jr, C. E., Avant, G. R. and Wilson, F. A. (1982) Anaerobic bacterial populations on normal and diseased human biopsy tissue obtained at colonoscopy. Appl. Environ. Microbiol. 43, 1173-1181
74. Kleessen, B., Kroesen, A. J., Buhr, H. J. and Blaut, M. (2002) Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand. J. Gastroenterol. 37, 1034-1041
75. Schultsz, C., Van Den Berg, F. M., Ten Kate, F. W., Tytgat, G. N. and Dankert, J. (1999) The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 117, 1089-1097
76. Swidsinski, A., Ladhoff, A., Pernthaler, A. et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122, 44-54
77. Ott, S. J., Musfeldt, M., Wenderoth, D. F. et al. (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53, 685-693
78. Pirzer, U., Schonhaar, A., Fleischer, B., Hermann, E. and Meyer zum Buschenfelde, K. H. (1991) Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease. Lancet 338, 1238-1239
79. Duchmann, R., Kaiser, I., Hermann, E., Mayet, W., Ewe, K. and Meyer zum Buschenfelde, K. H. (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102, 448-455
80. Mowat, A. M. (2003) Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3, 331-341
81. Hisamatsu, T., Suzuki, M., Reinecker, H. C., Nadeau, W. J., McCormick, B. A. and Podolsky, D. K. (2003) CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124, 993-1000
82. Rosenstiel, P., Fantini, M., Brautigam, K. et al. (2003) TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124, 1001-1009
83. Berrebi, D., Maudinas, R., Hugot, J. P. et al. (2003) Card 15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 52, 840-846
84. Otte, J. M., Rosenberg, I. M. and Podolsky, D. K. (2003) Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 124, 1866-1878
85. Lala, S., Ogura, Y., Osborne, C. et al. (2003) Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 125, 47-57
86. Ogura, Y., Lala, S., Xin, W. et al. (2003) Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52, 1591-1597
87. Tamboli, C. P., Neut, C., Desreumaux, P. and Colombel, J. F. (2004) Dysbiosis in inflammatory bowel disease. Gut 53, 1-4
88. Linskens, R. K., Huijsdens, X. W., Savelkoul, P. H., Vandenbroucke- Grauls, C. M. and Meuwissen, S. G. (2001) The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand. J. Gastroenterol. 88 (Suppl. 234) 29-40
89. Sears, C. L. (2001) The toxins of Bacteroides fragilis. Toxicon 39, 1737-1746
90. Sanfilippo, L., Li, C. K., Seth, R., Balwin, T. J., Menozzi, M. G. and Mahida, Y. R. (2000) Bacteroides fragilis enterotoxin induces the expression of IL-8 and transforming growth factor-β (TGF-β) by human colonic epithelial cells. Clin. Exp. Immunol. 119, 456-463
91. Schrezenmeir, J. and de Vrese, M. (2001) Probiotics, prebiotics, and synbiotics-approaching a definition. Am. J. Clin. Nutr. 73, 361S-364S
92. Gibson, G. R. and Roberfroid, M. B. (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125, 1401-1412
93. Lievin, V., Peiffer, I., Hudault, S. et al. (2000) Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47, 646-652
94. Neeser, J. R., Granato, D., Rouvet, M., Servin, A., Teneberg, S. and Karlsson, K. A. (2000) Lactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic bacteria. Glycobiology 10, 1193-1199
95. Resta-Lenert, S. and Barrett, K. E. (2003) Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52, 988-997
96. Madsen, K., Cornish, A., Soper, P. et al. (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580-591
97. Isolauri, E., Majamaa, H., Arvola, T., Rantala, I., Virtanen, E. and Arvilommi, H. (1993) Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 105, 1643-1650
98. Mack, D. R., Ahrne, S., Hyde, L., Wei, S. and Hollingsworth, M. A. (2003) Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52, 827-833
99. Yan, F. and Polk, D. B. (2002) Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J. Biol. Chem. 277, 50959-50965
100. Pathmakanthan, S., Li, C. K., Cowie, J. and Hawkey, C. J. (2004) Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon. J. Gastroenterol. Hepatol. 19, 166-173
101. Ouwehand, A. C., Salminen, S. and Isolauri, E. (2002) Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 82, 279-289
102. Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. and Isolauri, E. (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076-1079
103. Rachmilewitz, D., Karmeli, F., Takabayashi, K. et al. (2002) Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 122, 1428-1441
104. Sheil, B., McCarthy, J., O'Mahony, L. et al. (2004) Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 53, 694-700
105. Rachmilewitz, D., Katakura, K., Karmeli, F. et al. (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126, 520-528
106. Rembacken, B. J., Snelling, A. M., Hawkey, P. M., Chalmers, D. M. and Axon, A. T. (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354, 635-639
107. Gionchetti, P., Rizzello, F., Venturi, A. et al. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119, 305-309
108. Ruseler-van Embden, J. G., Schouten, W. R. and van Lieshout, L. M. (1994) Pouchitis: result of microbial imbalance? Gut 35, 658-664
109. Gionchetti, P., Rizzello, F., Helwig, U. et al. (2003) Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124, 1202-1209
110. Shiba, T., Aiba, Y., Ishikawa, H. et al. (2003) The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. Microbiol. Immunol. 47, 371-378
111. Cherbut, C., Michel, C. and Lecannu, G. (2003) The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J. Nutr. 133, 21-27
112. Shibolet, O., Karmeli, F., Eliakim, R. et al. (2002) Variable response to probiotics in two models of experimental colitis in rats. Inflamm. Bowel Dis. 8, 399-406
113. Kennedy, R. J., Hoper, M., Deodhar, K., Kirk, S. J. and Gardiner, K. R. (2000) Probiotic therapy fails to improve gut permeability in a hapten model of colitis. Scand. J. Gastroenterol. 35, 1266-1271
114. Holma, R., Salmenpera, P., Lohi, J., Vapaatalo, H. and Korpela, R. (2001) Effects of Lactobacillus rhamnosus GG and Lactobacillus reuteri R2LC on acetic acid-induced colitis in rats. Scand. J. Gastroenterol. 36, 630-635
115. Fabia, R., Ar'Rajab, A., Johansson, M. L. et al. (1993) The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat. Scand. J. Gastroenterol. 28, 155-162
116. McCarthy, J., O'Mahony, L., O'Callaghan, L. et al. (2003) Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52, 975-980
117. Schultz, M., Veltkamp, C., Dieleman, L. A. et al. (2002) Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm. Bowel Dis. 8, 71-80
118. O'Mahony, L., Feeney, M., O'Halloran, S. et al. (2001) Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment. Pharmacol. Ther. 15, 1219-1225
119. Madsen, K. L., Doyle, J. S., Jewell, L. D., Tavernini, M. M. and Fedorak, R. N. (1999) Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116, 1107-1114
120. Waidmann, M., Bechtold, O., Frick, J. S. et al. (2003) Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology 125, 162-177
121. Dieleman, L. A., Goerres, M. S., Arends, A. et al. (2003) Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52, 370-376
122. Holma, R., Juvonen, P., Asmawi, M. Z., Vapaatalo, H. and Korpela, R. (2002) Galacto-oligosaccharides stimulate the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats. Scand. J. Gastroenterol. 37, 1042-1047
123. Moreau, N. M., Martin, L. J., Toquet, C. S. et al. (2003) Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo-oligosaccharides, in dextran sulfate sodium-induced experimental colitis. Br. J. Nutr. 90, 75-85
124. Kanauchi, O., Serizawa, I., Araki, Y. et al. (2003) Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment. J. Gastroenterol. 38, 134-141
125. Fukuda, M., Kanauchi, O., Araki, Y. et al. (2002) Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment. Int. J. Mol. Med. 9, 65-70
126. Videla, S., Vilaseca, J., Antolin, M. et al. (2001) Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am. J. Gastroenterol. 96, 1486-1493
127. Kanauchi, O., Fujiyama, Y., Mitsuyama, K. et al. (1999) Increased growth of Bifidobacterium and Eubacterium by germinated barley foodstuff, accompanied by enhanced butyrate production in healthy volunteers. Int. J. Mol. Med. 3, 175-179
128. Ishikawa, H., Akedo, I., Umesaki, Y., Tanaka, R., Imaoka, A. and Otani, T. (2003) Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J. Am. Coll. Nutr. 22, 56-63
129. Prantera, C., Scribano, M. L., Falasco, G., Andreoli, A. and Luzi, C. (2002) Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 51,405-409